SCHEMBL4528074

SCHEMBL4528074

CC(=O)Nc1nc(C)c(-c2csc(NCc3ccccc3)n2)s1

nearest known ligand 0.80

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.80
MAPT P10636 6/20 0.80
MEN1 O00255 6/20 0.80
KMT2A Q03164 6/20 0.80
HPGD P15428 4/20 0.80
GAA P10253 3/20 0.80
NPSR1 Q6W5P4 2/20 0.80
PIK3CG P48736 7/20 0.71
LMNA P02545 4/20 0.69
HTT P42858 3/20 0.69
SMN1; SMN2 Q16637 3/20 0.69
HSD17B10 Q99714 2/20 0.69
L3MBTL1 Q9Y468 1/20 0.69
PI4KB Q9UBF8 4/20 0.69
KDM4E B2RXH2 3/20 0.68
RAB9A P51151 2/20 0.64
PKM P14618 1/20 0.64
POLB P06746 1/20 0.62
NPC1 O15118 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4525947 0.90 PI4KB (0.67) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL4530751 0.89 MAPT (0.81) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL4511208 0.89 PIK3CG (0.70) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL2835505 0.85 MEN1 (0.62) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL4522509 0.85 PIK3CG (0.68) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL4533996 0.83 PIK3CG (1.00) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL4524238 0.83 MEN1 (0.84) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL4513836 0.82 PIK3CG (0.81) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL4528106 0.81 PI4KB (1.00) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL4523664 0.81 PI4KB (0.74) ALDH1A1MAPTMEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8802861-B2 Thiazole derivatives and use thereof MERCK SERONO SA (CH) 2014-08-12 US claimed
US-20090029998-A1 Thiazole Derivatives and Use Thereof APPLIED RESEARCH SYSTEM ARS HOLDING N.V. (NL) 2009-01-29 US claimed
EP-1709019-B1 THIAZOLE DERIVATIVES AND USE THEREOF APPLIED RESEARCH SYSTEMS (AN) 2007-08-08 EP claimed
JP-2007517835-A 2007-07-05 JP claimed
EP-1709019-A2 THIAZOLE DERIVATIVES AND USE THEREOF Applied Research Systems ARS Holding N.V. (AN) 2006-10-11 EP claimed
WO-2005068444-A2 THIAZOLE DERIVATIVES AND USE THEREOF APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-07-28 WO claimed
US-9150561-B2 Thiazole derivatives and use thereof MERCK SERONO S.A. (CH) 2015-10-06 US disclosed
US-9150561-B2 Thiazole derivatives and use thereof MERCK SERONO S.A. (CH) 2015-10-06 US disclosed
US-20140228365-A1 THIAZOLE DERIVATIVES AND USE THEREOF MERCK SERONO S.A. (CH) 2014-08-14 US disclosed
US-20140228365-A1 THIAZOLE DERIVATIVES AND USE THEREOF MERCK SERONO S.A. (CH) 2014-08-14 US disclosed
US-8802861-B2 Thiazole derivatives and use thereof MERCK SERONO SA (CH) 2014-08-12 US disclosed
US-8802861-B2 Thiazole derivatives and use thereof MERCK SERONO SA (CH) 2014-08-12 US disclosed
US-8802861-B2 Thiazole derivatives and use thereof MERCK SERONO SA (CH) 2014-08-12 US disclosed
US-20090029998-A1 Thiazole Derivatives and Use Thereof APPLIED RESEARCH SYSTEM ARS HOLDING N.V. (NL) 2009-01-29 US disclosed
US-20090029998-A1 Thiazole Derivatives and Use Thereof APPLIED RESEARCH SYSTEM ARS HOLDING N.V. (NL) 2009-01-29 US disclosed
US-20090029998-A1 Thiazole Derivatives and Use Thereof APPLIED RESEARCH SYSTEM ARS HOLDING N.V. (NL) 2009-01-29 US disclosed
EP-1709019-B1 THIAZOLE DERIVATIVES AND USE THEREOF APPLIED RESEARCH SYSTEMS (AN) 2007-08-08 EP disclosed
EP-1709019-A2 THIAZOLE DERIVATIVES AND USE THEREOF Applied Research Systems ARS Holding N.V. (AN) 2006-10-11 EP disclosed
WO-2005068444-A2 THIAZOLE DERIVATIVES AND USE THEREOF APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-07-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140228365-A1 THIAZOLE DERIVATIVES AND USE THEREOF PF4, TEC, PDGFRB ALDH1A1 234/4885MAPT 4151/4885MEN1 1164/4885
US-20090029998-A1 Thiazole Derivatives and Use Thereof PDGFRB, PDGFRA, TEC ALDH1A1 174/4885MAPT 1418/4885MEN1 1761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.